SlideShare uma empresa Scribd logo
1 de 48
Overview   of  ICH GCP Syed Sarfaraz Uddin e-mail: syed.sarfaraz.uddin@gmail.com
What is ICH? ,[object Object]
How did it evolve? ,[object Object],[object Object],[object Object],[object Object],[object Object]
History ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
When did it begin?   ,[object Object],[object Object],[object Object],Industry Academia Ministry of health
ICH parties ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Key objective ,[object Object]
The result? ,[object Object],[object Object],[object Object],[object Object]
ICH Guidelines: examples ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The ICH Story Through the development of science-based, international guidelines and standards How: Reduce unnecessary duplication and thereby contribute to the efficiency of  drug development and registration for  new  pharmaceuticals Why: Regulatory authorities and research-based industry of the EU, US and Japan; WHO, EFTA and Canada observers Who:
What is GCP? ,[object Object]
Why is it needed?   ,[object Object],[object Object]
The ICH GCP guideline ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ICH GCP guideline ,[object Object]
ICH GCP guideline ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ICH GCP guideline ,[object Object],[object Object],[object Object],[object Object],[object Object]
Principles of ICH GCP ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Principles of ICH GCP ,[object Object],[object Object],[object Object],[object Object],[object Object]
Principles of ICH GCP ,[object Object],[object Object],[object Object],[object Object],[object Object]
Principles of ICH GCP ,[object Object],[object Object],[object Object]
Principles of ICH GCP ,[object Object],[object Object],[object Object]
Principles of ICH GCP ,[object Object],[object Object]
Concerns about ICH ,[object Object],[object Object],[object Object]
ICH vs. non-ICH ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Indian GCP guidelines   ,[object Object],[object Object],[object Object]
Issues in Developing Countries ,[object Object],[object Object],[object Object],[object Object]
ROLE OF GCP ? ,[object Object],[object Object],[object Object]
INTERNATIONAL ETHICAL STANDARDS ,[object Object],[object Object],[object Object]
Fundamental Ethical Principles Guiding Protection Of Human Subjects In Biomedical Research ,[object Object],[object Object],[object Object]
PRINCIPLES BEHIND GCP ,[object Object],[object Object],[object Object]
ETHICAL REVIEW SHOULD DEFINE JUSTIFIABLE BOUNDARIES BETWEEN THE RIGHTS OF THE SUBJECT AND THE BENEFITS THAT MIGHT ACCRUE TO SOCIETY THROUGH SCIENTIFIC INFORMATION DEVELOPED IN CLINICAL TRIALS. Regulations have been established internationally, to ensure ethical & scientific conduct of trials
GOALS OF INTERNATIONAL HARMONIZATION OF REGULATORY REQUIREMENTS ,[object Object],[object Object],[object Object],[object Object],[object Object]
STAKEHOLDERS & THEIR RELATIONSHIPS MONITOR DATA SUBJECT REGULATORY AUTHORITY SPONSOR ETHICS COMMITTEE INVESTIGATOR
ROLE OF ETHICS COMMITTEES ,[object Object],[object Object],[object Object],[object Object],[object Object]
Protection of Human Subjects Prior To Study Start ,[object Object],[object Object],[object Object],[object Object],[object Object]
Protection of Human Subjects   During the study ,[object Object],[object Object],[object Object]
RESPONSIBILITIES OF THE INVESTIGATOR ,[object Object],[object Object],[object Object],[object Object],[object Object]
RESPONSIBILITIES OF THE SPONSOR ,[object Object],[object Object],[object Object]
MEDICAL CARE OF TRIAL SUBJECTS ,[object Object],[object Object]
Protection of Human Subjects Informed Consent ,[object Object],[object Object],[object Object],[object Object],[object Object]
Study Documentation Before the study starts ,[object Object],[object Object],[object Object]
Study Documentation During the study ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Medical Records ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Study Documentation After the study ,[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],INVESTIGATIONAL PRODUCT
MONITORING ,[object Object],[object Object],[object Object],[object Object]
Questions?
 

Mais conteúdo relacionado

Mais procurados

Source Documents in Clinical Trials_part1
Source Documents in Clinical Trials_part1Source Documents in Clinical Trials_part1
Source Documents in Clinical Trials_part1
Valentyna Korniyenko
 
Essential Documents of Clinical Trials_2
Essential Documents of Clinical Trials_2Essential Documents of Clinical Trials_2
Essential Documents of Clinical Trials_2
heba rashed
 
responsibility of an investigator
responsibility of an investigatorresponsibility of an investigator
responsibility of an investigator
drodo2002
 
Data and safety monitoring boards
Data and safety monitoring boardsData and safety monitoring boards
Data and safety monitoring boards
Madhuri Miriyala
 

Mais procurados (20)

Source Documents in Clinical Trials_part1
Source Documents in Clinical Trials_part1Source Documents in Clinical Trials_part1
Source Documents in Clinical Trials_part1
 
Audits & Inspections in Clinical Research
Audits & Inspections in Clinical ResearchAudits & Inspections in Clinical Research
Audits & Inspections in Clinical Research
 
ICH-GCP AND THEIR DIFFIRENCES TO INDIAN CLINICAL TRIAL GUIDELINES
ICH-GCP AND THEIR DIFFIRENCES TO INDIAN CLINICAL TRIAL GUIDELINESICH-GCP AND THEIR DIFFIRENCES TO INDIAN CLINICAL TRIAL GUIDELINES
ICH-GCP AND THEIR DIFFIRENCES TO INDIAN CLINICAL TRIAL GUIDELINES
 
Good clinical practice
Good clinical practiceGood clinical practice
Good clinical practice
 
Roles and Responsibilities of sponsor, CRO, and investigator
Roles and Responsibilities of sponsor, CRO, and investigator Roles and Responsibilities of sponsor, CRO, and investigator
Roles and Responsibilities of sponsor, CRO, and investigator
 
Case report form and application
Case report  form  and  applicationCase report  form  and  application
Case report form and application
 
Sponsor Responsibilities ppt
Sponsor  Responsibilities pptSponsor  Responsibilities ppt
Sponsor Responsibilities ppt
 
Principle of good clinical practice
Principle of good clinical practicePrinciple of good clinical practice
Principle of good clinical practice
 
Informed consent process
Informed consent processInformed consent process
Informed consent process
 
Safety monitoring in clinical trails
Safety monitoring in clinical trailsSafety monitoring in clinical trails
Safety monitoring in clinical trails
 
ICH GCP
ICH GCPICH GCP
ICH GCP
 
ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTS
ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTSETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTS
ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTS
 
Phase 0 clinical trial
Phase 0 clinical trialPhase 0 clinical trial
Phase 0 clinical trial
 
Regulation in clinical trial, Schedule Y and recent amendments
Regulation in clinical trial, Schedule Y and recent amendmentsRegulation in clinical trial, Schedule Y and recent amendments
Regulation in clinical trial, Schedule Y and recent amendments
 
Guidelines for Preparation of Documents, Clinical Study Report Clinical Trial...
Guidelines for Preparation of Documents, Clinical Study Report Clinical Trial...Guidelines for Preparation of Documents, Clinical Study Report Clinical Trial...
Guidelines for Preparation of Documents, Clinical Study Report Clinical Trial...
 
Essential Documents of Clinical Trials_2
Essential Documents of Clinical Trials_2Essential Documents of Clinical Trials_2
Essential Documents of Clinical Trials_2
 
roles and responsibilities of Investigator[663]
roles and responsibilities of Investigator[663]roles and responsibilities of Investigator[663]
roles and responsibilities of Investigator[663]
 
Gcp 2013
Gcp 2013Gcp 2013
Gcp 2013
 
responsibility of an investigator
responsibility of an investigatorresponsibility of an investigator
responsibility of an investigator
 
Data and safety monitoring boards
Data and safety monitoring boardsData and safety monitoring boards
Data and safety monitoring boards
 

Semelhante a ICH GCP

OVERVIEW OF ICH-GCP GUIDELINES
OVERVIEW OF ICH-GCP GUIDELINESOVERVIEW OF ICH-GCP GUIDELINES
OVERVIEW OF ICH-GCP GUIDELINES
adityamalan2
 
Good clinical practice by vijay
Good clinical practice by vijayGood clinical practice by vijay
Good clinical practice by vijay
vijaypv
 

Semelhante a ICH GCP (20)

GCP and EC Training (2).ppt
GCP and EC Training (2).pptGCP and EC Training (2).ppt
GCP and EC Training (2).ppt
 
ICH GCP by Yogesh Yadav.pptx
ICH GCP by Yogesh Yadav.pptxICH GCP by Yogesh Yadav.pptx
ICH GCP by Yogesh Yadav.pptx
 
OVERVIEW OF ICH-GCP GUIDELINES
OVERVIEW OF ICH-GCP GUIDELINESOVERVIEW OF ICH-GCP GUIDELINES
OVERVIEW OF ICH-GCP GUIDELINES
 
ICH-GCP.pptx
ICH-GCP.pptxICH-GCP.pptx
ICH-GCP.pptx
 
Good clinical practise ppt
Good clinical       practise pptGood clinical       practise ppt
Good clinical practise ppt
 
Good clinical practices(GCP)
Good clinical practices(GCP)Good clinical practices(GCP)
Good clinical practices(GCP)
 
S1 KAVANA BB MBAT-Goos clinical Pratice.pptx
S1 KAVANA BB MBAT-Goos clinical Pratice.pptxS1 KAVANA BB MBAT-Goos clinical Pratice.pptx
S1 KAVANA BB MBAT-Goos clinical Pratice.pptx
 
Good clinical practice by vijay
Good clinical practice by vijayGood clinical practice by vijay
Good clinical practice by vijay
 
ICH GOOD CLINICAL PRACTICE
ICH GOOD CLINICAL PRACTICEICH GOOD CLINICAL PRACTICE
ICH GOOD CLINICAL PRACTICE
 
ICH GCP.ppt
ICH GCP.pptICH GCP.ppt
ICH GCP.ppt
 
Good Clinical Practice
Good Clinical PracticeGood Clinical Practice
Good Clinical Practice
 
GCP For M.Pharm
GCP For M.PharmGCP For M.Pharm
GCP For M.Pharm
 
Siobhan gaynor patientclinicalresearchtalkdec15
Siobhan gaynor   patientclinicalresearchtalkdec15Siobhan gaynor   patientclinicalresearchtalkdec15
Siobhan gaynor patientclinicalresearchtalkdec15
 
GCP guidelines
GCP guidelines GCP guidelines
GCP guidelines
 
C userstrishit.banerjee desktopamritaclinical research introduction phases a...
C userstrishit.banerjee desktopamritaclinical research  introduction phases a...C userstrishit.banerjee desktopamritaclinical research  introduction phases a...
C userstrishit.banerjee desktopamritaclinical research introduction phases a...
 
GCP ppdf
GCP ppdfGCP ppdf
GCP ppdf
 
What is clinical research? Why to do it?
What is clinical research? Why to do it?What is clinical research? Why to do it?
What is clinical research? Why to do it?
 
GCP-Good Clinical Practice
GCP-Good Clinical PracticeGCP-Good Clinical Practice
GCP-Good Clinical Practice
 
Gcp guidelines
Gcp guidelinesGcp guidelines
Gcp guidelines
 
Schedule y
Schedule  ySchedule  y
Schedule y
 

ICH GCP

  • 1. Overview of ICH GCP Syed Sarfaraz Uddin e-mail: syed.sarfaraz.uddin@gmail.com
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10. The ICH Story Through the development of science-based, international guidelines and standards How: Reduce unnecessary duplication and thereby contribute to the efficiency of drug development and registration for new pharmaceuticals Why: Regulatory authorities and research-based industry of the EU, US and Japan; WHO, EFTA and Canada observers Who:
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31. ETHICAL REVIEW SHOULD DEFINE JUSTIFIABLE BOUNDARIES BETWEEN THE RIGHTS OF THE SUBJECT AND THE BENEFITS THAT MIGHT ACCRUE TO SOCIETY THROUGH SCIENTIFIC INFORMATION DEVELOPED IN CLINICAL TRIALS. Regulations have been established internationally, to ensure ethical & scientific conduct of trials
  • 32.
  • 33. STAKEHOLDERS & THEIR RELATIONSHIPS MONITOR DATA SUBJECT REGULATORY AUTHORITY SPONSOR ETHICS COMMITTEE INVESTIGATOR
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.
  • 45.
  • 46.
  • 48.  

Notas do Editor

  1. Helsinki declaration was adopted by World Medical Assembly in 1964, amended in Tokyo in 1975, in Venice in 1983 and subsequently in Hong Kong in 1989. The most important principle being “Interests of the subject must always prevail over the interests of science and society.” However, this declaration does not necessitate informed consent for therapeutic trials and only requires documentation of reasons for not obtaining the same. The physician is obliged to preserve the accuracy of the results. Thus GCP ensures the credibility of the data.
  2. Most of the current requirements of ethical protection are as a result of reaction by the public, scientific community and politicians in response to reports of abuse of trial subjects during 1960’s and 70’s.